|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 31/14 | (2006.01) |
| A61K 38/07 | (2006.01) | ||
| A61K 38/06 | (2006.01) | ||
| A61K 38/08 | (2006.01) | ||
| C07K 5/08 | (2006.01) | ||
| C07K 5/10 | (2006.01) | ||
| C07K 5/12 | (2006.01) |
| (11) | Number of the document | 2310095 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09790553.3 |
| Date of filing the European patent application | 2009-07-17 | |
| (97) | Date of publication of the European application | 2011-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-29 |
| (46) | Date of publication of the claims translation | 2013-02-25 |
| (86) | Number | PCT/US2009/050915 |
| Date | 2009-07-17 |
| (87) | Number | WO 2010/011566 |
| Date | 2010-01-28 |
| (30) | Number | Date | Country code |
| 135559 P | 2008-07-22 | US |
| (72) |
HARPER, Steven, IT
SUMMA, Vincenzo, IT
LIVERTON, Nigel J., US
MCCAULEY, Johh A., US
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
MSD ITALIA S.r.l., Via Vitorchiano 151, 00189 Roma, IT |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Makrocikliniai chinoksalino junginiai kaip HCV NS3 proteazės inhibitoriai |
| MACROCYCLIC QUINOXALINE COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-06-16 | 17 | 347.00 EUR |
| 2026-07-17 |